{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T02:55:40Z","timestamp":1776740140398,"version":"3.51.2"},"reference-count":55,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The outcome for children with high-grade gliomas (HGG) remains dismal, with a 2-year survival rate of only 10% to 30%. Diffuse intrinsic pontine glioma (DIPG) comprise a subset of HGG that arise in the brainstem almost exclusively in children. Genome-wide analyses of copy number imbalances previously showed that platelet-derived growth factor receptor \u03b1 (PDGFRA) is the most frequent target of focal amplification in pediatric HGGs, including DIPGs. To determine whether PDGFRA is also targeted by more subtle mutations missed by copy number analysis, we sequenced all PDGFRA coding exons from a cohort of pediatric HGGs. Somatic-activating mutations were identified in 14.4% (13 of 90) of nonbrainstem pediatric HGGs and 4.7% (2 of 43) of DIPGs, including missense mutations and in-frame deletions and insertions not previously described. Forty percent of tumors with mutation showed concurrent amplification, whereas 60% carried heterozygous mutations. Six different mutations impacting different domains all resulted in ligand-independent receptor activation that was blocked by small molecule inhibitors of PDGFR. Expression of mutants in p53-null primary mouse astrocytes conferred a proliferative advantage in vitro and generated HGGs in vivo with complete penetrance when implanted into brain. The gene expression signatures of these murine HGGs reflected the spectrum of human diffuse HGGs. PDGFRA intragenic deletion of exons 8 and 9 were previously shown in adult HGG, but were not detected in 83 nonbrainstem pediatric HGG and 57 DIPGs. Thus, a distinct spectrum of mutations confers constitutive receptor activation and oncogenic activity to PDGFR\u03b1 in childhood HGG. Cancer Res; 73(20); 6219\u201329. \u00a92013 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-13-1491","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T00:48:31Z","timestamp":1377218911000},"page":"6219-6229","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":199,"title":["Novel Oncogenic\n                    <i>PDGFRA<\/i>\n                    Mutations in Pediatric High-Grade Gliomas"],"prefix":"10.1158","volume":"73","author":[{"given":"Barbara S.","family":"Paugh","sequence":"first","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Xiaoyan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Chunxu","family":"Qu","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Raelene","family":"Endersby","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Alexander K.","family":"Diaz","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"},{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Junyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Dorine A.","family":"Bax","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Diana","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Rui M.","family":"Reis","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Arzu","family":"Onar-Thomas","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Alberto","family":"Broniscer","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Cynthia","family":"Wetmore","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Jinghui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Chris","family":"Jones","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"David W.","family":"Ellison","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]},{"given":"Suzanne J.","family":"Baker","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"},{"name":"Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, S\u00e3o Paulo, Brazil"}]}],"member":"1086","published-online":{"date-parts":[[2013,10,14]]},"reference":[{"key":"2022061703522452400_bib1","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1002\/cncr.24663","article-title":"Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the surveillance, epidemiology, and end results database","volume":"115","author":"Qaddoumi","year":"2009","journal-title":"Cancer"},{"key":"2022061703522452400_bib2","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0883073808321765","article-title":"Chemotherapy for malignant brain tumors of childhood","volume":"23","author":"Gottardo","year":"2008","journal-title":"J Child Neurol"},{"key":"2022061703522452400_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fonc.2012.00205","article-title":"Diffuse intrinsic pontine glioma: poised for progress","volume":"2","author":"Warren","year":"2012","journal-title":"Front Oncol"},{"key":"2022061703522452400_bib4","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","article-title":"Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma","volume":"29","author":"Paugh","year":"2011","journal-title":"J Clin Oncol"},{"key":"2022061703522452400_bib5","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","article-title":"Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease","volume":"28","author":"Paugh","year":"2010","journal-title":"J Clin Oncol"},{"key":"2022061703522452400_bib6","doi-asserted-by":"crossref","first-page":"e30313","DOI":"10.1371\/journal.pone.0030313","article-title":"Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas","volume":"7","author":"Puget","year":"2012","journal-title":"PloS ONE"},{"key":"2022061703522452400_bib7","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1200\/JCO.2009.25.5463","article-title":"Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets","volume":"28","author":"Zarghooni","year":"2010","journal-title":"J Clin Oncol"},{"key":"2022061703522452400_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"McLendon","year":"2008","journal-title":"Nature"},{"key":"2022061703522452400_bib9","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"2022061703522452400_bib10","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1158\/1078-0432.CCR-10-0438","article-title":"A distinct spectrum of copy number aberrations in pediatric high-grade gliomas","volume":"16","author":"Bax","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2022061703522452400_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"key":"2022061703522452400_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"2022061703522452400_bib13","first-page":"418","article-title":"Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort","volume":"105","author":"Pollack","year":"2006","journal-title":"J Neurosurg"},{"key":"2022061703522452400_bib14","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1101\/gad.1596707","article-title":"Malignant astrocytic glioma: genetics, biology, and paths to treatment","volume":"21","author":"Furnari","year":"2007","journal-title":"Genes Dev"},{"key":"2022061703522452400_bib15","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev"},{"key":"2022061703522452400_bib16","first-page":"F79","article-title":"Signal transduction via platelet-derived growth factor receptors","volume":"1378","author":"Heldin","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"2022061703522452400_bib17","first-page":"5275","article-title":"Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus","volume":"58","author":"Uhrbom","year":"1998","journal-title":"Cancer Res"},{"key":"2022061703522452400_bib18","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gad.903001","article-title":"PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo","volume":"15","author":"Dai","year":"2001","journal-title":"Genes Dev"},{"key":"2022061703522452400_bib19","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/onc.2009.76","article-title":"Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma","volume":"28","author":"Lindberg","year":"2009","journal-title":"Oncogene"},{"key":"2022061703522452400_bib20","first-page":"4305","article-title":"Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model","volume":"63","author":"Hesselager","year":"2003","journal-title":"Cancer Res"},{"key":"2022061703522452400_bib21","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/glia.21142","article-title":"Genetic modeling of gliomas in mice: new tools to tackle old problems","volume":"59","author":"Hambardzumyan","year":"2011","journal-title":"Glia"},{"key":"2022061703522452400_bib22","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1128\/MCB.00099-07","article-title":"EWS\/FLI-1 induces rapid onset of myeloid\/erythroid leukemia in mice","volume":"27","author":"Torchia","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2022061703522452400_bib23","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1101\/gad.1972310","article-title":"PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas","volume":"24","author":"Ozawa","year":"2010","journal-title":"Genes Dev"},{"key":"2022061703522452400_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood.V93.2.488","article-title":"Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis","volume":"93","author":"Persons","year":"1999","journal-title":"Blood"},{"key":"2022061703522452400_bib25","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1158\/0008-5472.CAN-10-3597","article-title":"Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model","volume":"71","author":"Endersby","year":"2011","journal-title":"Cancer Res"},{"key":"2022061703522452400_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"2022061703522452400_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"2022061703522452400_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"2022061703522452400_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ccr.2011.01.039","article-title":"Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain","volume":"19","author":"Chow","year":"2011","journal-title":"Cancer Cell"},{"key":"2022061703522452400_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis","volume":"9","author":"Phillips","year":"2006","journal-title":"Cancer Cell"},{"key":"2022061703522452400_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1523\/JNEUROSCI.4178-07.2008","article-title":"A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function","volume":"28","author":"Cahoy","year":"2008","journal-title":"J Neurosci"},{"key":"2022061703522452400_bib32","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1200\/JCO.2005.14.068","article-title":"PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib","volume":"23","author":"Corless","year":"2005","journal-title":"J Clin Oncol"},{"key":"2022061703522452400_bib33","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00000478-200407000-00007","article-title":"KIT-negative gastrointestinal stromal tumors: proof-of-concept and therapeutic implications","volume":"28","author":"Medeiros","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"2022061703522452400_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"2022061703522452400_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1620\/tjem.168.265","article-title":"Overexpression and amplification of alpha-PDGF receptor gene lacking exons coding for a portion of the extracellular region in a malignant glioma","volume":"168","author":"Kumabe","year":"1992","journal-title":"Tohoku J Exp Med"},{"key":"2022061703522452400_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1097-2765(04)00050-4","article-title":"Shp2 regulates SRC family kinase activity and Ras\/Erk activation by controlling Csk recruitment","volume":"13","author":"Zhang","year":"2004","journal-title":"Mol Cell"},{"key":"2022061703522452400_bib37","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1128\/MCB.16.12.6926","article-title":"Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation","volume":"16","author":"Bazenet","year":"1996","journal-title":"Mol Cell Biol"},{"key":"2022061703522452400_bib38","first-page":"3780","article-title":"Tyrosine mutations within the alpha platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated phosphatidylinositol-3 kinase activity without affecting mitogenic or chemotactic signal transduction","volume":"11","author":"Yu","year":"1991","journal-title":"Mol Cell Biol"},{"key":"2022061703522452400_bib39","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo","year":"2004","journal-title":"J Med Chem"},{"key":"2022061703522452400_bib40","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1073\/pnas.0504952102","article-title":"Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases","volume":"102","author":"Carter","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061703522452400_bib41","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1200\/JCO.2009.21.8487","article-title":"Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancers","volume":"27","author":"Lewis","year":"2009","journal-title":"J Clin Oncol"},{"key":"2022061703522452400_bib42","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1158\/1078-0432.CCR-12-0625","article-title":"Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors","volume":"18","author":"Heinrich","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2022061703522452400_bib43","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbamem.2009.12.016","article-title":"Strong oligomerization behavior of PDGFbeta receptor transmembrane domain and its regulation by the juxtamembrane regions","volume":"1798","author":"Oates","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"2022061703522452400_bib44","doi-asserted-by":"crossref","first-page":"38627","DOI":"10.1074\/jbc.M204890200","article-title":"Definition of an inhibitory juxtamembrane WW-like domain in the platelet-derived growth factor beta receptor","volume":"277","author":"Irusta","year":"2002","journal-title":"J Biol Chem"},{"key":"2022061703522452400_bib45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"2022061703522452400_bib46","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1158\/0008-5472.CAN-09-2503","article-title":"Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma","volume":"70","author":"Becher","year":"2010","journal-title":"Cancer Res"},{"key":"2022061703522452400_bib47","doi-asserted-by":"crossref","first-page":"e20041","DOI":"10.1371\/journal.pone.0020041","article-title":"Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype","volume":"6","author":"Lei","year":"2011","journal-title":"PloS ONE"},{"key":"2022061703522452400_bib48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuron.2006.06.012","article-title":"PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling","volume":"51","author":"Jackson","year":"2006","journal-title":"Neuron"},{"key":"2022061703522452400_bib49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI43690","article-title":"SHP-2\/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A\/ARF aberrations in mice and humans","volume":"121","author":"Liu","year":"2011","journal-title":"J Clin Invest"},{"key":"2022061703522452400_bib50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1535-6108(02)00046-6","article-title":"Epidermal growth factor receptor and Ink4a\/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis","volume":"1","author":"Bachoo","year":"2002","journal-title":"Cancer Cell"},{"key":"2022061703522452400_bib51","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1101\/gad.200907.112","article-title":"Pediatric glioma-associated KIAA1549: BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner","volume":"26","author":"Kaul","year":"2012","journal-title":"Genes Dev"},{"key":"2022061703522452400_bib52","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1038\/sj.onc.1210455","article-title":"Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma","volume":"26","author":"Tchougounova","year":"2007","journal-title":"Oncogene"},{"key":"2022061703522452400_bib53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.01.008","article-title":"Mutant BRAF melanomas\u2013dependence and resistance","volume":"19","author":"Poulikakos","year":"2011","journal-title":"Cancer Cell"},{"key":"2022061703522452400_bib54","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1158\/1078-0432.CCR-07-2248","article-title":"Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer","volume":"14","author":"Engelman","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2022061703522452400_bib55","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1158\/2159-8290.CD-11-0284","article-title":"Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors","volume":"2","author":"Vivanco","year":"2012","journal-title":"Cancer Discov"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/73\/20\/6219\/2689994\/6219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/73\/20\/6219\/2689994\/6219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T09:19:43Z","timestamp":1655457583000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/73\/20\/6219\/584775\/Novel-Oncogenic-PDGFRA-Mutations-in-Pediatric-High"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,14]]},"references-count":55,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2013,10,14]]},"published-print":{"date-parts":[[2013,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-13-1491","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22397553","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22397550.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22397550","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22397544.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22397547.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22397553.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22397556.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22397547","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22397544","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22397556","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6504858.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6504858","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,14]]}}}